| Financial Year |
March 31 2023 |
| Monetary Funds |
101,128,316,229.65 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
150,239,532.00 |
| Accounts Receivable |
88,451,118.86 |
| Advances to Suppliers |
219,163,842.54 |
| Other Receivables |
49,505,076.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
16,065,154,749.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
144,222,015,604.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,986,387,524.78 |
| Investment Properties |
-- |
| Fixed Assetes |
5,254,759,793.22 |
| Under-construction Projects |
4,138,068,313.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
556,251,031.34 |
| R&D expenses |
-- |
| Goodwill |
1,621,619.53 |
| Long-Term Deferred and Prepaid Expenses |
150,870,410.78 |
| Deferred Income Tax Assets |
2,135,102,844.63 |
| Other Non-Current Assets |
1,680,184,441.59 |
| Sub-Total of Non-Current Assets |
16,199,121,489.03 |
| Total Assets |
160,421,137,093.80 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,171,773,522.51 |
| Accounts Payable |
7,492,576,221.73 |
| Accounts Received In Advance |
16,420,891.54 |
| Employee Compensation Payable |
3,277,054,744.92 |
| Taxes Payable |
7,064,942,200.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,813,775,934.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
295,822,667.64 |
| Other Current Liabilities |
619,467,710.17 |
| Sub-Total of Current Liabilities |
30,287,625,004.78 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
73,016,546.47 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
340,009,147.59 |
| Total Liabilities |
30,627,634,152.37 |
| Paid-In Capital(Or Share Stock) |
3,881,608,005.00 |
| Capital Surplus |
2,682,647,086.15 |
| Surplus Reserve |
28,432,482,367.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
91,573,245,966.29 |
| Minority Stockholder's Interest |
3,223,519,516.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
126,569,983,424.82 |
| Owner's Equity（Stockholder's Equity） |
129,793,502,941.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
160,421,137,093.80 |
